| Literature DB >> 25881319 |
Zhaoming Liang1,2, Bixia Ke3, Xiaoling Deng4, Junhua Liang5, Lu Ran6, Lingling Lu7, Dongmei He8, Qiong Huang9, Changwen Ke10, Zhongjie Li11, Hongjie Yu12, John D Klena13,14, Shuyu Wu15.
Abstract
BACKGROUND: Non-typhoidal Salmonella is a common cause of infectious diarrhea in humans. Antimicrobial-resistant Salmonella has become a global concern.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25881319 PMCID: PMC4343067 DOI: 10.1186/s12879-015-0784-4
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Descriptive data of infections by serotype in diarrhea patients in Guangdong province in 2009 – 2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Season | |||||||||||||
| Spring | 100 (38) | 35 (13) | 41 (16) | 23 (8.8) | 6 (2.3) | 4 (1.5) | 7 (2.7) | 0 (0.0) | 6 (2.3) | 1 (0.4) | 2 (0.8) | 36 (14) | 261 (100) |
| Summer | 184 (27) | 111 (16) | 88 (13) | 59 (8.7) | 23 (3.4) | 23 (3.4) | 10 (1.5) | 10 (1.5) | 5 (0.7) | 10 (1.5) | 12 (1.8) | 145 (21) | 680 (100) |
| Autumn | 213 (30) | 87 (12) | 88 (12) | 96 (14) | 14 (2.0) | 13 (1.8) | 14 (2.0) | 18 (2.5) | 11 (1.6) | 9 (1.3) | 5 (0.7) | 140 (20) | 708 (100) |
| Winter | 53 (30) | 21 (12) | 28 (16) | 11 (6.2) | 5 (2.8) | 3 (1.7) | 7 (4.0) | 1 (0.6) | 4 (2.3) | 0 (0.0) | 1 (0.6) | 43 (24) | 117 (100) |
| Sex | |||||||||||||
| Male | 324 (31) | 151 (15) | 125 (12) | 102 (10) | 27 (2.6) | 24 (2.3) | 25 (2.4) | 16 (1.6) | 15 (1.5) | 8 (0.8) | 12 (1.2) | 202 (20) | 1031 (100) |
| Female | 200 (28) | 98 (14) | 109 (15) | 81 (11) | 20 (2.8) | 16 (2.2) | 12 (1.7) | 11 (1.5) | 8 (1.1) | 12 (1.7) | 8 (1.1) | 150 (21) | 725 (100) |
| Unknown | 26 (37) | 5 (7.1) | 11 (16) | 6 (8.6) | 1 (1.4) | 3 (4.3) | 1 (1.4) | 2 (2.9) | 3 (4.3) | 0 (0.0) | 0 (0.0) | 12 (17) | 70 (100) |
| Age | |||||||||||||
| ≤1 | 404 (37) | 189 (17) | 74 (6.8) | 120 (11) | 24 (2.2) | 26 (2.4) | 13 (1.2) | 18 (1.7) | 13 (1.2) | 10 (0.9) | 10 (0.9) | 183 (17) | 1084 (100) |
| ~2 | 41 (21) | 32 (17) | 34 (18) | 35 (18) | 5 (2.6) | 2 (1.0) | 0 (0.0) | 2 (1.0) | 5 (2.6) | 3 (1.6) | 4 (2.1) | 29 (15) | 192 (100) |
| ~3 | 24 (28) | 10 (9.1) | 24 (22) | 7 (6.4) | 4 (3.6) | 1 (0.9) | 7 (6.4) | 3 (2.7) | 1 (0.9) | 0 (0.0) | 2 (1.8) | 27 (24) | 110 (100) |
| ~4) | 12 (17) | 3 (4.3) | 22 (32) | 6 (8.7) | 1 (1.4) | 1 (1.4) | 4 (5.8) | 0 (0.0) | 2 (2.9) | 3 (4.3) | 1 (1.4) | 14 (20) | 69 (100) |
| ~5 | 9 (19) | 4 (8.5) | 18 (38) | 2 (4.3) | 1 (2.1) | 0 (0.0) | 1 (2.1) | 1 (2.1) | 0 (0.0) | 1 (2.1) | 0 (0.0) | 10 (21) | 47 (100) |
| ≥5 | 20 (9.6) | 7 (3.3) | 54 (26) | 11 (5.3) | 10 (4.8) | 9 (4.3) | 12 (5.7) | 3 (1.4) | 2 (1.0) | 3 (1.4) | 3 (1.4) | 75 (36) | 209 (100) |
| Unknown | 40 (35) | 9 (7.8) | 19 (16) | 8 (7.0) | 3 (2.6) | 4 (3.5) | 1 (0.9) | 2 (1.7) | 3 (2.6) | 0 (0.0) | 0 (0.0) | 26 (23) | 115 (100) |
| Overall | 550 (30) | 254 (14) | 245 (13) | 189 (10) | 48 (2.6) | 43 (2.4) | 38 (2.1) | 29 (1.6) | 26 (1.4) | 20 (1.1) | 20 (1.1) | 364 (20) | 1826 (100) |
Antimicrobial resistance of serotypes in Guangdong province in 2009 - 2012
|
|
|
|
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Aminoglycosides | ||||||||||||
| Getamicin | 302 (66) | 32 (65) | 131 (57) | 10 (71) | 14 (12) | 13 (12) | 11 (6.9) | 1 (4.8) | 8 (27) | 6 (40) | 3 (11) | 3 (27) |
| Streptomycin | 335 (73) | 36 (74) | 154 (67) | 9 (64) | 44 (36) | 41 (39) | 22 (14) | 1 (4.8) | 10 (33) | 7 (47) | 13 (46) | 6 (54) |
| Cephalosporins | ||||||||||||
| Cefepime | 71 (15) | 3 (6.1) | 29 (13) | 1 (7.1) | 14 (12) | 6 (5.7) | 9 (5.6) | 0 (0.0) | 3 (10) | 0 (0.0) | 5 (18) | 0 (0.0) |
| Cefotaxime | 67 (14) | 5 (10) | 30 (13) | 0 (0.0) | 12 (10) | 5 (4.8) | 10 (6.3) | 1 (4.8) | 3 (10) | 0 (0.0) | 5 (18) | 0 (0.0) |
| Caftazidime | 45 (9.8) | 2 (4.1) | 18 (7.8) | 0 (0.0) | 7 (5.8) | 5 (4.8) | 8 (5.0) | 1 (4.8) | 1 (3.3) | 0 (0.0) | 3 (11) | 0 (0.0) |
| Penicillins | ||||||||||||
| Ampicillin | 412 (89) | 35 (71) | 215 (93) | 11 (79) | 68 (56) | 59 (56) | 18 (11) | 3 (14) | 12 (40) | 6 (40) | 21 (75) | 8 (73) |
| Quinolones | ||||||||||||
| Nalidixic acid | 383 (83) | 37 (76) | 167 (73) | 13 (93) | 94 (78) | 89 (85) | 17 (11) | 1 (4.8) | 11 (37) | 7 (47) | 3 (11) | 1 (9.1) |
| Ciprofloxacin | 56 (12) | 5 (10) | 27 (12) | 1 (7.1) | 7 (5.8) | 7 (6.7) | 8 (5.0) | 0 (0.0) | 1 (3.3) | 3 (20) | 1 (3.6) | 0 (0.0) |
| Tetracyclines | ||||||||||||
| Tetracycline | 402 (87) | 34 (69) | 214 (93) | 13 (93) | 32 (26) | 28 (27) | 22 (14) | 1 (4.8) | 21 (70) | 8 (53) | 25 (89) | 8 (73) |
| Amphenicols | ||||||||||||
| Chloramphenicol | 335 (73) | 28 (57) | 154 (67) | 9 (64) | 5 (4.1) | 5 (4.8) | 8 (5.0) | 2 (9.5) | 9 (30) | 6 (40) | 4 (14) | 1 (9.1) |
| Sulfonamides | ||||||||||||
| Sulfamethoxazole | 398 (86) | 35 (71) | 206 (89) | 12 (86) | 60 (50) | 53 (50) | 31 (19) | 3 (14) | 15 (50) | 7 (47) | 21 (75) | 5 (46) |
| Trimethoprim | 298 (65) | 27 (55) | 117 (51) | 8 (57) | 16 (13) | 10 (9.5) | 10 (6.3) | 2 (9.5) | 8 (27) | 6 (40) | 24 (86) | 9 (82) |
| Multi-resistance | ||||||||||||
| ≥3 antimicrobials | 356 (77) | 31 (63) | 188 (81) | 9 (64) | 65 (54) | 73 (70) | 49 (31) | 7 (33) | 15 (50) | 6 (40) | 22 (79) | 8 (73) |
| ACSSuT* | 244 (53) | 25 (51) | 92 (40) | 6 (43) | 3 (2.5) | 3 (2.9) | 2 (1.3) | 1 (4.8) | 6 (20) | 4 (27) | 3 (11) | 1 (9.1) |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Aminoglycosides | ||||||||||||
| Getamicin | 3 (23) | 1 (4.2) | 2 (10) | 2 (29) | 2 (10) | 1 (25) | 3 (27) | 1 (11) | 4 (29) | 1 (17) | 37 (17) | 19 (16) |
| Streptomycin | 3 (23) | 3 (12) | 2 (10) | 2 (29) | 12 (63) | 3 (75) | 3 (27) | 3 (33) | 4 (29) | 2 (33) | 61 (28) | 37 (32) |
| Cephalosporins | ||||||||||||
| Cefepime | 3 (23) | 1 (4.2) | 2 (10) | 2 (29) | 1 (5.3) | 1 (25) | 4 (36) | 1 (11) | 3 (21) | 1 (17) | 20 (9.0) | 19 (16) |
| Cefotaxime | 2 (15) | 0 (0.0) | 3 (15) | 0 (0.0) | 5 (26) | 1 (25) | 4 (36) | 0 (0.0) | 2 (14) | 0 (0.0) | 0 (0.0) | 9 (7.7) |
| Caftazidime | 2 (15) | 0 (0.0) | 2 (10) | 0 (0.0) | 6 (32) | 1 (25) | 3 (27) | 0 (0.0) | 2 (14) | 1 (17) | 16 (7.2) | 7 (6.0) |
| Penicillins | ||||||||||||
| Ampicillin | 1 (7.7) | 2 (8.3) | 16 (80) | 6 (86) | 12 (63) | 1 (25) | 11 (100) | 9 (100) | 3 (21) | 2 (33) | 79 (36) | 33 (28) |
| Quinolones | ||||||||||||
| Nalidixic acid | 2 (15) | 2 (8.3) | 16 (80) | 5 (71) | 5 (26) | 2 (50) | 9 (82) | 9 (100) | 4 (29) | 0 (0.0) | 71 (32) | 36 (31) |
| Ciprofloxacin | 0 (0.0) | 1 (4.2) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (50) | 1 (9.1) | 0 (0.0) | 3 (21) | 1 (17) | 19 (8.6) | 4 (3.4) |
| Tetracyclines | ||||||||||||
| Tetracycline | 2 (15) | 4 (17) | 11 (55) | 6 (86) | 13 (68) | 2 (50) | 9 (82) | 9 (100) | 6 (43) | 2 (33) | 82 (37) | 52 (44) |
| Amphenicols | ||||||||||||
| Chloramphenicol | 0 (0.0) | 2 (8.3) | 12 (60) | 6 (86) | 7 (37) | 2 (50) | 9 (82) | 9 (100) | 3 (21) | 2 (33) | 45 (20) | 16 (14) |
| Sulfonamides | ||||||||||||
| Sulfamethoxazole | 3 (23) | 5 (21) | 15 (75) | 6 (86) | 14 (74) | 2 (50) | 10 (91) | 9 (100) | 3 (21) | 1 (17) | 79 (36) | 50 (43) |
| Trimethoprim | 1 (7.7) | 3 (12) | 13 (65) | 4 (57) | 8 (42) | 2 (50) | 9 (82) | 9 (100) | 2 (14) | 1 (17) | 51 (23) | 37 (32) |
| Multi-resistance | ||||||||||||
| ≥3 antimicrobials | 4 (31) | 12 (50) | 13 (65) | 3 (43) | 16 (84) | 4 (100) | 9 (82) | 8 (89) | 5 (36) | 4 (67) | 106 (48) | 62 (53) |
| ACSSuT* | 0 (0.0) | 0 (0.0) | 1 (5.0) | 2 (29) | 6 (32) | 1 (25) | 3 (27) | 3 (33) | 1 (7.1) | 1 (17) | 25 (11) | 12 (10) |
*Resistance to ampicillin, chloramphenicol, streptomycin, sulfamethoxazole, tetracycline.
Figure 1Antimicrobial resistance rate of different antimicrobial agents inNon-typhoidal Salmonella in Guangdong, 2009–2012.